Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Exploratory Phase II Clinical Trial, Double-blind, Randomized Placebo-controlled to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers

NCT04903184 is registered in ClinicalTrials.gov with RUTI Immunotherapeutics S.L. as lead sponsor.

NCT NCT04903184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04903184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Exploratory Phase II Clinical Trial, Double-blind, Randomized Placebo-controlled to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers
Lead sponsor
RUTI Immunotherapeutics S.L.
Phase
Phase 2
Overall status
Completed
Start date
January 6, 2021
Completion date
November 11, 2021
Enrollment
251 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19